{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:59:09Z","timestamp":1780948749644,"version":"3.54.1"},"reference-count":51,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA07272, K23DA048161, R01DA041425, R24DA051950"],"award-info":[{"award-number":["DA07272, K23DA048161, R01DA041425, R24DA051950"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2022,1,28]]},"DOI":"10.1080\/10826084.2021.2012687","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T09:54:39Z","timestamp":1639475679000},"page":"316-327","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Motivations for Prescription Drug Misuse Related to Mental Health Problems in Adults"],"prefix":"10.1080","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-0780","authenticated-orcid":false,"given":"Tess K.","family":"Drazdowski","sequence":"first","affiliation":[{"name":"UCLA Integrated Substance Abuse Programs, Los Angeles, California, USA"},{"name":"Oregon Social Learning Center, Eugene, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya","family":"Schulte","sequence":"additional","affiliation":[{"name":"UCLA Integrated Substance Abuse Programs, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6199-4350","authenticated-orcid":false,"given":"Kate B.","family":"Wolitzky-Taylor","sequence":"additional","affiliation":[{"name":"UCLA Integrated Substance Abuse Programs, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holle","family":"Schaper","sequence":"additional","affiliation":[{"name":"Oregon Social Learning Center, Eugene, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Oregon Social Learning Center, Eugene, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"CIT0001","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","edition":"4"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719002307"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2174\/1874473710801030255"},{"issue":"6","key":"CIT0004","first-page":"735","volume":"3","author":"Bernert R. A.","year":"2007","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"CIT0005","volume-title":"2016 National Survey on Drug Use and Health: Methodological summary and definitions","author":"Center for Behavioral Health Statistics and Quality.","year":"2017"},{"key":"CIT0006","volume-title":"2017 National Survey on Drug Use and Health: Methodological summary and definitions","author":"Center for Behavioral Health Statistics and Quality.","year":"2018"},{"key":"CIT0007","volume-title":"2018 National Survey on Drug Use and Health: Detailed tables","author":"Center for Behavioral Health Statistics and Quality.","year":"2019"},{"key":"CIT0008","unstructured":"Center for Substance Abuse Treatment. (2013) Enhancing motivation for change in substance abuse treatment. (Treatment Improvement Protocol (TIP) Series No. No. 35. HHS Publication No. (SMA) 13-4212). Substance Abuse and Mental Health Services Administration."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17091048"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.020"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.15288\/qjsa.1956.17.296"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.01.011"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"CIT0015","volume-title":"Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition (SCID-I\/NP)","author":"First M. B.","year":"2002"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.8.807"},{"key":"CIT0017","first-page":"17m11973","volume":"79","author":"Han B.","year":"2018","journal-title":"Journal of Clinical Psychiatry"},{"key":"CIT0019","volume-title":"Drug overdose deaths in the United States, 1999\u20132018. NCHS Data Brief, no 356","author":"Hedegaard H.","year":"2020"},{"key":"CIT0021","unstructured":"IBM. (2019). SPSS Statistics for Windows (Version 26, released 2019) [Computer software]. Armonk, NY: IBM Corporation."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.005"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.2.184"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1837-8_7"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2011.03.003"},{"key":"CIT0029","volume-title":"Behavioral activation for depression: A clinician\u2019s guide","author":"Martell C. R.","year":"2010"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711002145"},{"issue":"1","key":"CIT0031","first-page":"29","volume":"96","author":"Matheson E.","year":"2017","journal-title":"American Family Physician"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2009.120"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.01.007"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2006.05.022"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.11.1415"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1246"},{"key":"CIT0038","author":"Murphy S. L.","year":"2018","journal-title":"NCHS Data Brief"},{"key":"CIT0039","unstructured":"National Institute on Drug Abuse. (2014). Prescription and over-the-counter medications. http:\/\/www.drugabuse.gov\/publications\/drugfacts\/prescription-over-counter-medications"},{"key":"CIT0040","unstructured":"National Institute on Drug Abuse. (2021, April 13). What is the scope of prescription drug misuse? https:\/\/www.drugabuse.gov\/publications\/research-reports\/misuse-prescription-drugs\/what-scope-prescription-drug-misuse"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.313"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2367"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796020000037"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1177\/1178221820909352"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000736"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1002\/da.10128"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-74290-8_13"},{"key":"CIT0052","unstructured":"Substance Abuse and Mental Health Data Archive. (2014). How do I account for complex sampling design when analyzing NSDUH data? http:\/\/samhda-faqs.blogspot.com\/2014\/03\/how-do-i-account-complex-sampling.html"},{"key":"CIT0053","volume-title":"Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings","author":"Substance Abuse and Mental Health Services Administration","year":"2010"},{"key":"CIT0054","volume-title":"2018 National Survey on Drug Use and Health: Methodological summary and definitions","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000603"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2087"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2841"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1080\/1067828X.2017.1420507"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2012.03.026"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2021.2012687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T17:57:48Z","timestamp":1645120668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2021.2012687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,28]]}},"alternative-id":["10.1080\/10826084.2021.2012687"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2021.2012687","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}